Review



celltrace (yellow cell proliferation kit)  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Thermo Fisher celltrace (yellow cell proliferation kit)
    Celltrace (Yellow Cell Proliferation Kit), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/celltrace (yellow cell proliferation kit)/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    celltrace (yellow cell proliferation kit) - by Bioz Stars, 2026-03
    90/100 stars

    Images



    Similar Products

    90
    Thermo Fisher celltrace (yellow cell proliferation kit)
    Celltrace (Yellow Cell Proliferation Kit), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/celltrace (yellow cell proliferation kit)/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    celltrace (yellow cell proliferation kit) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher celltrace™ yellow cell proliferation kit
    Celltrace™ Yellow Cell Proliferation Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/celltrace™ yellow cell proliferation kit/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    celltrace™ yellow cell proliferation kit - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher celltrace yellow cell proliferation kit
    Cytokine production and <t>proliferation</t> of murine ILC2 upon treatment with distinct cytokine combinations. Bone marrow-derived (A, B, E, F) or lung-derived (C, D) group 2 innate lymphoid cells (ILC2) were stimulated with either IL-7 only, IL-33 only, or a combination of IL-7 and IL-33 (A, C, E) or IL-2 only, IL-33 only, or a combination of IL-2 and IL-33 (B, D, F) . All cytokines were applied at 10 ng/mL. (A–D) After 24 hours of stimulation, supernatants were harvested and analyzed for IL-5 content by ELISA. (E, F) Proliferation of ILC2 was assessed using <t>CellTrace</t> Yellow Cell Proliferation Kit after 3 days of incubation with respective cytokines. The data representing the IL-33 stimulation is the same for (A–F) . Data are representative of three independent experiments with stimulations performed in duplicates. Data are shown as average ± standard deviation (SD). Statistical analysis was performed using one-way ANOVA followed by Tukey’s multiple comparisons test (p < 0.01 = ** and p < 0.0001 = ****); ND, not detectable.
    Celltrace Yellow Cell Proliferation Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/celltrace yellow cell proliferation kit/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    celltrace yellow cell proliferation kit - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher celltrace yellow proliferation kit (#c34567)
    A: Workflow to identify 5 FDA-approved compounds with transcriptional profiles similar to lead LRA using CMap analysis. Figure created with BioRender. B: CD69 MFI of matched cultured T CM (n = 9) were measured by flow cytometry after treatment with 30 IU/mL IL-2 or IL-2 plus 100 μ M HODHBt or 10 μ M of indicated compounds for 72 hours. Significant p values over cells treated with IL-2 alone. C: Reactivation of latent HIV in T CM (n = 7) measured by flow cytometry after treatment with 100 μ M HODHBt or 10 μ M Isotretinoin alone, plus 100 ng/mL IL-15, or α CD3/CD28. D: Calculation of synergy for LRA combinations using the Bliss independence model (n = 7). Data is presented as the difference between the observed and expected fractional response. E: Viability of uninfected or latently infected matched conditions (n = 7). F: Memory CD4 T cells were stained with <t>CellTrace</t> yellow and treated with 100 μ M HODHBt or 10 μ M Isotretinoin alone or in combination with 100 ng/mL IL-15, or α CD3/CD28 for 7 days. <t>Proliferation</t> was measured by flow cytometry (n = 5). Wilcoxon matched-pairs signed rank test was used to calculate p values (*p < 0.05; **p < 0.01).
    Celltrace Yellow Proliferation Kit (#C34567), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/celltrace yellow proliferation kit (#c34567)/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    celltrace yellow proliferation kit (#c34567) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    86
    Thermo Fisher celltrace yellow cell proliferation kit invitrogen cat no c34567
    A: Workflow to identify 5 FDA-approved compounds with transcriptional profiles similar to lead LRA using CMap analysis. Figure created with BioRender. B: CD69 MFI of matched cultured T CM (n = 9) were measured by flow cytometry after treatment with 30 IU/mL IL-2 or IL-2 plus 100 μ M HODHBt or 10 μ M of indicated compounds for 72 hours. Significant p values over cells treated with IL-2 alone. C: Reactivation of latent HIV in T CM (n = 7) measured by flow cytometry after treatment with 100 μ M HODHBt or 10 μ M Isotretinoin alone, plus 100 ng/mL IL-15, or α CD3/CD28. D: Calculation of synergy for LRA combinations using the Bliss independence model (n = 7). Data is presented as the difference between the observed and expected fractional response. E: Viability of uninfected or latently infected matched conditions (n = 7). F: Memory CD4 T cells were stained with <t>CellTrace</t> yellow and treated with 100 μ M HODHBt or 10 μ M Isotretinoin alone or in combination with 100 ng/mL IL-15, or α CD3/CD28 for 7 days. <t>Proliferation</t> was measured by flow cytometry (n = 5). Wilcoxon matched-pairs signed rank test was used to calculate p values (*p < 0.05; **p < 0.01).
    Celltrace Yellow Cell Proliferation Kit Invitrogen Cat No C34567, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/celltrace yellow cell proliferation kit invitrogen cat no c34567/product/Thermo Fisher
    Average 86 stars, based on 1 article reviews
    celltrace yellow cell proliferation kit invitrogen cat no c34567 - by Bioz Stars, 2026-03
    86/100 stars
      Buy from Supplier

    90
    Thermo Fisher celltrace yellow proliferation kit c34567
    A: Workflow to identify 5 FDA-approved compounds with transcriptional profiles similar to lead LRA using CMap analysis. Figure created with BioRender. B: CD69 MFI of matched cultured T CM (n = 9) were measured by flow cytometry after treatment with 30 IU/mL IL-2 or IL-2 plus 100 μ M HODHBt or 10 μ M of indicated compounds for 72 hours. Significant p values over cells treated with IL-2 alone. C: Reactivation of latent HIV in T CM (n = 7) measured by flow cytometry after treatment with 100 μ M HODHBt or 10 μ M Isotretinoin alone, plus 100 ng/mL IL-15, or α CD3/CD28. D: Calculation of synergy for LRA combinations using the Bliss independence model (n = 7). Data is presented as the difference between the observed and expected fractional response. E: Viability of uninfected or latently infected matched conditions (n = 7). F: Memory CD4 T cells were stained with <t>CellTrace</t> yellow and treated with 100 μ M HODHBt or 10 μ M Isotretinoin alone or in combination with 100 ng/mL IL-15, or α CD3/CD28 for 7 days. <t>Proliferation</t> was measured by flow cytometry (n = 5). Wilcoxon matched-pairs signed rank test was used to calculate p values (*p < 0.05; **p < 0.01).
    Celltrace Yellow Proliferation Kit C34567, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/celltrace yellow proliferation kit c34567/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    celltrace yellow proliferation kit c34567 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    86
    Thermo Fisher celltrace yellow proliferation kit
    A: Workflow to identify 5 FDA-approved compounds with transcriptional profiles similar to lead LRA using CMap analysis. Figure created with BioRender. B: CD69 MFI of matched cultured T CM (n = 9) were measured by flow cytometry after treatment with 30 IU/mL IL-2 or IL-2 plus 100 μ M HODHBt or 10 μ M of indicated compounds for 72 hours. Significant p values over cells treated with IL-2 alone. C: Reactivation of latent HIV in T CM (n = 7) measured by flow cytometry after treatment with 100 μ M HODHBt or 10 μ M Isotretinoin alone, plus 100 ng/mL IL-15, or α CD3/CD28. D: Calculation of synergy for LRA combinations using the Bliss independence model (n = 7). Data is presented as the difference between the observed and expected fractional response. E: Viability of uninfected or latently infected matched conditions (n = 7). F: Memory CD4 T cells were stained with <t>CellTrace</t> yellow and treated with 100 μ M HODHBt or 10 μ M Isotretinoin alone or in combination with 100 ng/mL IL-15, or α CD3/CD28 for 7 days. <t>Proliferation</t> was measured by flow cytometry (n = 5). Wilcoxon matched-pairs signed rank test was used to calculate p values (*p < 0.05; **p < 0.01).
    Celltrace Yellow Proliferation Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/celltrace yellow proliferation kit/product/Thermo Fisher
    Average 86 stars, based on 1 article reviews
    celltrace yellow proliferation kit - by Bioz Stars, 2026-03
    86/100 stars
      Buy from Supplier

    Image Search Results


    Cytokine production and proliferation of murine ILC2 upon treatment with distinct cytokine combinations. Bone marrow-derived (A, B, E, F) or lung-derived (C, D) group 2 innate lymphoid cells (ILC2) were stimulated with either IL-7 only, IL-33 only, or a combination of IL-7 and IL-33 (A, C, E) or IL-2 only, IL-33 only, or a combination of IL-2 and IL-33 (B, D, F) . All cytokines were applied at 10 ng/mL. (A–D) After 24 hours of stimulation, supernatants were harvested and analyzed for IL-5 content by ELISA. (E, F) Proliferation of ILC2 was assessed using CellTrace Yellow Cell Proliferation Kit after 3 days of incubation with respective cytokines. The data representing the IL-33 stimulation is the same for (A–F) . Data are representative of three independent experiments with stimulations performed in duplicates. Data are shown as average ± standard deviation (SD). Statistical analysis was performed using one-way ANOVA followed by Tukey’s multiple comparisons test (p < 0.01 = ** and p < 0.0001 = ****); ND, not detectable.

    Journal: Frontiers in Immunology

    Article Title: Analysis of lipid uptake, storage, and fatty acid oxidation by group 2 innate lymphoid cells

    doi: 10.3389/fimmu.2024.1493848

    Figure Lengend Snippet: Cytokine production and proliferation of murine ILC2 upon treatment with distinct cytokine combinations. Bone marrow-derived (A, B, E, F) or lung-derived (C, D) group 2 innate lymphoid cells (ILC2) were stimulated with either IL-7 only, IL-33 only, or a combination of IL-7 and IL-33 (A, C, E) or IL-2 only, IL-33 only, or a combination of IL-2 and IL-33 (B, D, F) . All cytokines were applied at 10 ng/mL. (A–D) After 24 hours of stimulation, supernatants were harvested and analyzed for IL-5 content by ELISA. (E, F) Proliferation of ILC2 was assessed using CellTrace Yellow Cell Proliferation Kit after 3 days of incubation with respective cytokines. The data representing the IL-33 stimulation is the same for (A–F) . Data are representative of three independent experiments with stimulations performed in duplicates. Data are shown as average ± standard deviation (SD). Statistical analysis was performed using one-way ANOVA followed by Tukey’s multiple comparisons test (p < 0.01 = ** and p < 0.0001 = ****); ND, not detectable.

    Article Snippet: Bone marrow ILC2 were stained with CellTrace Yellow Cell Proliferation Kit (Invitrogen, Catalog No. C34573) according to manufacturer’s instructions.

    Techniques: Derivative Assay, Enzyme-linked Immunosorbent Assay, Incubation, Standard Deviation

    A: Workflow to identify 5 FDA-approved compounds with transcriptional profiles similar to lead LRA using CMap analysis. Figure created with BioRender. B: CD69 MFI of matched cultured T CM (n = 9) were measured by flow cytometry after treatment with 30 IU/mL IL-2 or IL-2 plus 100 μ M HODHBt or 10 μ M of indicated compounds for 72 hours. Significant p values over cells treated with IL-2 alone. C: Reactivation of latent HIV in T CM (n = 7) measured by flow cytometry after treatment with 100 μ M HODHBt or 10 μ M Isotretinoin alone, plus 100 ng/mL IL-15, or α CD3/CD28. D: Calculation of synergy for LRA combinations using the Bliss independence model (n = 7). Data is presented as the difference between the observed and expected fractional response. E: Viability of uninfected or latently infected matched conditions (n = 7). F: Memory CD4 T cells were stained with CellTrace yellow and treated with 100 μ M HODHBt or 10 μ M Isotretinoin alone or in combination with 100 ng/mL IL-15, or α CD3/CD28 for 7 days. Proliferation was measured by flow cytometry (n = 5). Wilcoxon matched-pairs signed rank test was used to calculate p values (*p < 0.05; **p < 0.01).

    Journal: PLOS Pathogens

    Article Title: Isotretinoin promotes elimination of translation-competent HIV latent reservoirs in CD4T cells

    doi: 10.1371/journal.ppat.1012601

    Figure Lengend Snippet: A: Workflow to identify 5 FDA-approved compounds with transcriptional profiles similar to lead LRA using CMap analysis. Figure created with BioRender. B: CD69 MFI of matched cultured T CM (n = 9) were measured by flow cytometry after treatment with 30 IU/mL IL-2 or IL-2 plus 100 μ M HODHBt or 10 μ M of indicated compounds for 72 hours. Significant p values over cells treated with IL-2 alone. C: Reactivation of latent HIV in T CM (n = 7) measured by flow cytometry after treatment with 100 μ M HODHBt or 10 μ M Isotretinoin alone, plus 100 ng/mL IL-15, or α CD3/CD28. D: Calculation of synergy for LRA combinations using the Bliss independence model (n = 7). Data is presented as the difference between the observed and expected fractional response. E: Viability of uninfected or latently infected matched conditions (n = 7). F: Memory CD4 T cells were stained with CellTrace yellow and treated with 100 μ M HODHBt or 10 μ M Isotretinoin alone or in combination with 100 ng/mL IL-15, or α CD3/CD28 for 7 days. Proliferation was measured by flow cytometry (n = 5). Wilcoxon matched-pairs signed rank test was used to calculate p values (*p < 0.05; **p < 0.01).

    Article Snippet: CellTrace Yellow proliferation kit (#C34567) was purchased from Invitrogen.

    Techniques: Cell Culture, Flow Cytometry, Infection, Staining